Page 1 of Clinical Trials for International AIDS Vaccine Initiative [SPONSOR-COLLABORATORS], 16 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
A Trial to Evaluate the Safety and Immunogenicity of Ad26-ENVA and Ad35-ENV HIV Vaccines in Healthy HIV-uninfected Adult Volunteers
Last Updated: April 23, 2012
Condition(s): HIV Infections
2
Completed
Safety and Immunogenicity of a Plasmid HIV Vaccine, ADVAX e/g + ADVAX p/N-t (ADVAX), in HIV Uninfected Adults.
Last Updated: September 12, 2011
Condition(s): HIV Infection
3
Completed
Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults
Last Updated: June 15, 2010
Condition(s): HIV Infection
4
Completed
A Trial to Evaluate the Safety and Immunogenicity of TBC-M4, an Env, Gag, Tat-rev, and Nef-RT MVA HIV Vaccine and a Prime-Boost Regimen With ADVAX, an Env, Gag, Nef-tat and Pol DNA HIV Vaccine and TBC-M4
Last Updated: November 11, 2010
Condition(s): HIV Infections
5
Completed
Safety and Immunogenicity Study of tgAAC09, a Gag-PR-RT AAV HIV Vaccine
Last Updated: June 1, 2007
Condition(s): HIV Infections
6
Completed
A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-Risk Populations in Kenya, Africa
Last Updated: August 5, 2010
Condition(s): HIV Infections
7
Active, not recruiting
A Trial to Evaluate the Safety and Immunogenicity of an Adjuvanted GSK Investigational HIV Vaccine Administered With Ad35-GRIN Investigational Vaccine
Last Updated: April 23, 2012
Condition(s): HIV Infections
8
Completed
A Trial to Evaluate the Safety and Immunogenicity of tgAAC09, an HIV Vaccine Containing Clade C Gag-PR-ΔRT DNA in an Adeno-associated Virus (AAV) Capsid, Administered Twice, at Three Dosage Levels and Two Dosing Intervals
Last Updated: January 5, 2010
Condition(s): Human Immunodeficiency Virus Infections; HIV Infections
9
Completed
A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-risk Populations in Uganda, Africa
Last Updated: August 24, 2011
Condition(s): HIV Infection
10
Completed
A Phase IIA Trial to Evaluate the Safety and Immunogenicity of a DNA HIV-1 Vaccine Followed by an MVA HIV-1 Vaccine in HIV-uninfected Volunteers
Last Updated: June 9, 2011
Condition(s): HIV Infections
11
Completed
A Trial to Evaluate Ad35-GRIN/ENV HIV Vaccine in Healthy Adult Volunteers
Last Updated: April 23, 2012
Condition(s): HIV; HIV Infections
12
Active, not recruiting
Safety and Immunogenicity Study of HIV-MAG Vaccine Co-administered With Human IL-12 pDNA Followed or Preceded by Ad35-GRIN/ENV HIV Vaccine in HIV-uninfected Volunteers
Last Updated: May 4, 2012
Condition(s): HIV Infections
13
Withdrawn
Safety and Effectiveness of an HIV DNA Vaccine Followed by an HIV Adenoviral Vector Vaccine for Prevention of HIV Infection in the Americas and Africa
Last Updated: March 23, 2012
Condition(s): HIV Infections
14
Completed
Study of a Potential Preventive Vaccine Against HIV in Healthy Volunteers
Last Updated: May 4, 2011
Condition(s): HIV Infections
15
Withdrawn
Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African Adults
Last Updated: March 20, 2012
Condition(s): HIV Infections
16
Recruiting
Safety Study of Four Chimera Cytomegalovirus (CMV) Vaccines in Healthy Adult Males 30-50 Years of Age
Last Updated: November 10, 2011
Condition(s): Cytomegalovirus

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=International+AIDS+Vaccine+Initiative

Page 1 of Clinical Trials for International AIDS Vaccine Initiative [SPONSOR-COLLABORATORS], 16 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About